• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞抗原I类表达、自然杀伤细胞浸润及其与腔面型乳腺癌预后特征的相关性

Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers.

作者信息

Vernet-Tomas Maria, Vazquez Ivonne, Olivares Francesc, Lopez David, Yelamos Jose, Comerma Laura

机构信息

Breast Diseases Unit, Hospital Del Mar, Barcelona, Spain.

Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

出版信息

Breast Cancer (Dove Med Press). 2024 Oct 5;16:657-666. doi: 10.2147/BCTT.S476721. eCollection 2024.

DOI:10.2147/BCTT.S476721
PMID:39387059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11463177/
Abstract

PURPOSE

The aim of this study was to determine whether low HLA-I expression and NK cells infiltration are related to prognostic features in breast cancer, as observed in cancers in other locations and non-hormone dependent breast cancers. Particularly, we explored their relation to infiltrated axillary lymph nodes (ALNs), with the aim of finding new predictors helping to decide the extent of axillary surgery.

PATIENTS AND METHODS

We conducted a retrospective correlational analysis of 35 breast cancers from 35 breast cancer patients showing axillary infiltration at diagnosis and with upfront surgery. HLA-I H-score and the number of NK cells x 50 high power fields (HPF) in the biopsy specimen were correlated with pathological variables of the surgical specimen: number of infiltrated ALNs, tumor size, histological type, the presence of ductal carcinoma in situ, focality, histological grade, necrosis, lymphovascular and perineural invasion, Her2Neu status, and the percentages of tumor-infiltrating lymphocytes (TILs), estrogen receptor, progesterone receptor, ki67, and p53.

RESULTS

All tumors showed hormone receptor expression and three of them Her2Neu positivity. A positive correlation (p=0.001**) was found between HLA-I H-score and TILs and Ki67 expression. HLA H-score increased with histological grade and was higher in unifocal than in multifocal disease (p=0.044 and p=0.011, respectively). No other correlations were found.

CONCLUSION

High HLA-I H-score values correlated with features of poor prognosis in this cohort of luminal breast tumors, but not with infiltrated ALNs. This finding highlights the differences between luminal breast cancer, and cancers in other locations and non-hormone dependent breast cancers, in which low HLA-I expression tends to be associated with poor prognostic features.

摘要

目的

本研究旨在确定低HLA-I表达和自然杀伤(NK)细胞浸润是否与乳腺癌的预后特征相关,正如在其他部位癌症和非激素依赖性乳腺癌中所观察到的那样。特别是,我们探讨了它们与腋窝淋巴结转移(ALNs)的关系,旨在寻找有助于确定腋窝手术范围的新预测指标。

患者与方法

我们对35例乳腺癌患者的35例乳腺癌进行了回顾性相关性分析,这些患者在诊断时显示腋窝浸润并接受了前期手术。活检标本中的HLA-I H评分和NK细胞数量×50高倍视野(HPF)与手术标本的病理变量相关:腋窝淋巴结转移数量、肿瘤大小、组织学类型、原位导管癌的存在、灶性、组织学分级、坏死、淋巴管和神经周围浸润、Her2Neu状态,以及肿瘤浸润淋巴细胞(TILs)、雌激素受体、孕激素受体、ki67和p53的百分比。

结果

所有肿瘤均显示激素受体表达,其中3例为Her2Neu阳性。发现HLA-I H评分与TILs和Ki67表达之间存在正相关(p = 0.001**)。HLA H评分随组织学分级增加,单灶性疾病中的评分高于多灶性疾病(分别为p = 0.044和p = 0.011)。未发现其他相关性。

结论

在这一管腔型乳腺肿瘤队列中,高HLA-I H评分值与预后不良特征相关,但与腋窝淋巴结转移无关。这一发现突出了管腔型乳腺癌与其他部位癌症和非激素依赖性乳腺癌之间的差异,在其他部位癌症和非激素依赖性乳腺癌中,低HLA-I表达往往与预后不良特征相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/4be401fae17f/BCTT-16-657-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/0feeff78e230/BCTT-16-657-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/8cabc0b2f21d/BCTT-16-657-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/4be401fae17f/BCTT-16-657-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/0feeff78e230/BCTT-16-657-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/8cabc0b2f21d/BCTT-16-657-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c3/11463177/4be401fae17f/BCTT-16-657-g0003.jpg

相似文献

1
Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers.人白细胞抗原I类表达、自然杀伤细胞浸润及其与腔面型乳腺癌预后特征的相关性
Breast Cancer (Dove Med Press). 2024 Oct 5;16:657-666. doi: 10.2147/BCTT.S476721. eCollection 2024.
2
Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.原发性乳腺癌腋窝淋巴结转移阳性的预后因素
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Mar 1;38(1):81-90. doi: 10.1515/prilozi-2017-0011.
3
Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.乳腺癌中的Ki67指数:与其他预后标志物的相关性及在巴基斯坦患者中的潜力
Asian Pac J Cancer Prev. 2013;14(7):4353-8. doi: 10.7314/apjcp.2013.14.7.4353.
4
Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.不同分子亚型乳腺癌患者中p53、KI67和BRCA1表达的比较及其与病理和预后的关系。
J BUON. 2019 Nov-Dec;24(6):2361-2368.
5
Impact of Size of the Tumour, Persistence of Estrogen Receptors, Progesterone Receptors, HER2Neu Receptors and Ki67 Values on Positivity of Axillary Lymph Nodes in Patients with Early Breast Cancer with Clinically Negative Axillary Examination.肿瘤大小、雌激素受体、孕激素受体、HER2Neu受体的持续存在及Ki67值对腋窝检查临床阴性的早期乳腺癌患者腋窝淋巴结阳性的影响
Open Access Maced J Med Sci. 2017 Oct 26;5(7):825-830. doi: 10.3889/oamjms.2017.213. eCollection 2017 Dec 15.
6
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers.人表皮生长因子受体2(Her2neu)阳性(非管腔型)原发性乳腺癌亚型的临床及预后特征:与Her2neu阳性管腔型乳腺癌的比较
BMC Res Notes. 2018 Aug 13;11(1):574. doi: 10.1186/s13104-018-3677-y.
7
Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling.主要组织相容性复合体I类分子在乳腺癌亚型中的差异表达与雌激素受体及干扰素信号传导相关。
Oncotarget. 2016 May 24;7(21):30119-32. doi: 10.18632/oncotarget.8798.
8
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.乳腺癌中肿瘤浸润淋巴细胞亚群的预后价值取决于激素受体状态。
Breast Cancer Res Treat. 2017 Feb;161(3):409-420. doi: 10.1007/s10549-016-4072-9. Epub 2016 Dec 2.
9
Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study.FOXP3 +肿瘤浸润淋巴细胞与CCL20表达的协同关联与原发性乳腺癌预后不良:一项回顾性队列研究。
Medicine (Baltimore). 2019 Dec;98(50):e18403. doi: 10.1097/MD.0000000000018403.
10
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.抗黏液病毒A(MxA)的表达与人类表皮生长因子受体2(HER2)阳性乳腺癌中的肿瘤浸润淋巴细胞相关。
Cancer Res Treat. 2017 Apr;49(2):313-321. doi: 10.4143/crt.2016.098. Epub 2016 Jul 7.

本文引用的文献

1
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment.乳腺癌的病因、进展、预后标志物及治疗的全面综述。
Med Oncol. 2023 Jul 14;40(8):238. doi: 10.1007/s12032-023-02111-9.
2
Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.HLA Ⅰ类分子的表达与乳腺癌免疫细胞浸润和患者预后相关。
Sci Rep. 2022 Nov 27;12(1):20367. doi: 10.1038/s41598-022-24890-3.
3
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis.
非侵入性预测乳腺癌腋窝淋巴结负担的指标:单机构回顾性分析。
Breast Cancer Res Treat. 2022 Sep;195(2):161-169. doi: 10.1007/s10549-022-06672-7. Epub 2022 Jul 21.
4
Dynamic Changes in Uterine NK Cell Subset Frequency and Function Over the Menstrual Cycle and Pregnancy.子宫 NK 细胞亚群频率和功能在月经周期和妊娠期间的动态变化。
Front Immunol. 2022 Jun 16;13:880438. doi: 10.3389/fimmu.2022.880438. eCollection 2022.
5
Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.乳腺癌患者肿瘤浸润自然杀伤细胞(TINK)亚群及功能分子
Mol Immunol. 2021 Aug;136:161-167. doi: 10.1016/j.molimm.2021.03.003. Epub 2021 Jun 23.
6
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.富含免疫细胞的雌激素受体阳性与富含免疫细胞的三阴性乳腺癌之间的免疫学差异
JCO Precis Oncol. 2020 Jun 26;4. doi: 10.1200/PO.19.00350. eCollection 2020.
7
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.免疫细胞在乳腺组织中的作用及免疫疗法在乳腺癌治疗中的应用。
Clin Breast Cancer. 2021 Feb;21(1):e63-e73. doi: 10.1016/j.clbc.2020.06.011. Epub 2020 Jul 2.
8
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.绝经激素治疗与妇女健康倡议随机临床试验长期随访中乳腺癌发病率和死亡率的关系。
JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482.
9
Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis.子宫内膜异位症患者的杀伤细胞免疫球蛋白样受体(KIR)和人类白细胞抗原-C(HLA-C)同种异体识别模式。
Sci Rep. 2020 Mar 17;10(1):4897. doi: 10.1038/s41598-020-61702-y.
10
Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.基于基因表达谱的乳腺癌肿瘤浸润免疫细胞亚型分类及特征基因分析
J Cancer. 2020 Jan 14;11(6):1568-1583. doi: 10.7150/jca.37637. eCollection 2020.